Mukuchyan, Vahan
19  results:
Search for persons X
?
1

Efficacy and safety of curcumin and its combination with bo..:

Haroyan, Armine ; Mukuchyan, Vahan ; Mkrtchyan, Nana...
BMC Complementary and Alternative Medicine.  18 (2018)  1 - p. , 2018
 
?
2

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
3

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
4

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
 
?
6

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
7

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
8

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
9

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
10

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
11

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
12

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
13

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
14

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
?
15

Intravenous versus subcutaneous tocilizumab in Takayasu art..:

Mekinian, Arsène ; Biard, Lucie ; Lorenzo, Dagna...
info:eu-repo/semantics/altIdentifier/doi/10.1136/rmdopen-2022-002830.  , 2023
 
1-15